Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Science (New York, N.Y.)
|
December 16, 2020
Inferring the effectiveness of government interventions against COVID-19
Jan M Brauner, Sören Mindermann, Mrinank Sharma, et al.
Nature Communications
|
October 6, 2021
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
Mrinank Sharma, Sören Mindermann, Charlie Rogers-Smith, et al.
Microbial Genomics
|
June 11, 2024
PHA4GE quality control contextual data tags: standardized annotations for sharing public health sequence datasets with known quality issues to facilitate testing and training
Emma J Griffiths, Inês Mendes, Finlay Maguire, et al.
The Lancet. Microbe
|
April 4, 2022
The 2021 WHO catalogue of <i>Mycobacterium tuberculosis</i> complex mutations associated with drug resistance: A genotypic analysis
Timothy M Walker, Paolo Miotto, Claudio U Köser, et al.
Scientific Reports
|
February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
Matthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Scientific Reports
|
October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
Matthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
The European Respiratory Journal
|
December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>
Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Global Health
|
August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health
|
August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Science (New York, N.Y.)
|
December 16, 2020
Inferring the effectiveness of government interventions against COVID-19
Jan M Brauner, Sören Mindermann, Mrinank Sharma, et al.
Nature Communications
|
October 6, 2021
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
Mrinank Sharma, Sören Mindermann, Charlie Rogers-Smith, et al.
Microbial Genomics
|
June 11, 2024
PHA4GE quality control contextual data tags: standardized annotations for sharing public health sequence datasets with known quality issues to facilitate testing and training
Emma J Griffiths, Inês Mendes, Finlay Maguire, et al.
The Lancet. Microbe
|
April 4, 2022
The 2021 WHO catalogue of <i>Mycobacterium tuberculosis</i> complex mutations associated with drug resistance: A genotypic analysis
Timothy M Walker, Paolo Miotto, Claudio U Köser, et al.
Scientific Reports
|
February 22, 2020
Author Correction: Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
Matthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
Scientific Reports
|
October 20, 2018
Integrating standardized whole genome sequence analysis with a global Mycobacterium tuberculosis antibiotic resistance knowledgebase
Matthew Ezewudo, Amanda Borens, Álvaro Chiner-Oms, et al.
The European Respiratory Journal
|
December 30, 2017
A standardised method for interpreting the association between mutations and phenotypic drug resistance in <i>Mycobacterium tuberculosis</i>
Paolo Miotto, Belay Tessema, Elisa Tagliani, et al.
The Lancet. Global Health
|
August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health
|
August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models
Jeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Page
of 6